Skip to main content
. 2020 Feb 3;10(9):5241–5259. doi: 10.1039/c9ra10505k

Antibacterial and antifungal activities of non-irradiated and gamma-irradiated CoxNi1−xFe2O4; x = 0.9/SiO2/TiO2 nanocomposite against pathogenic microbes measured as ZOI (mm) and MIC (μg ml−1)a.

Pathogenic microbes ZOI of non-irradiated CoxNi1−xFe2O4/SiO2/TiO2; x = 0.9 NPs (mm) ZOI of irradiated CoxNi1−xFe2O4/SiO2/TiO2; x = 0.9 NPs (25.0 kGy) (mm) ZOI of irradiated CoxNi1−xFe2O4/SiO2/TiO2; x = 0.9 NPs (50.0 kGy) (mm) ZOI of irradiated CoxNi1−xFe2O4/SiO2/TiO2; x = 0.9 NPs (100.0 kGy) (mm) MIC of irradiated CoxNi1−xFe2O4/SiO2/TiO2; x = 0.9 NPs (100.0 kGy) (μg ml−1) AMC or NS
Escherichia coli 17.0b ± 0.3214 25.0f ± 0.4509 27.0h ± 0.2645 30.0h ± 0.4163 0.024 Nil
Pseudomonas aeruginosa 11.0a ± 0.2645 18.0d ± 0.4509 19.0e ± 0.2516 20.0e ± 0.2516 0.390 Nil
Staphylococcus aureus; MRSA 12.0a ± 0.1808 19.0.0e ± 0.5507 22.0g ± 0.2081 25.0g ± 0.2645 0.097 Nil
Bacillus subtilus 10.0a ± 0.4725 12.0.0b ± 0.2645 14.0d ± 0.3214 16.0d ± 0.4582 1.562 Nil
Proteus mirabilis 11.0a ± 0.2000 13.0a ± 0.2516 13.0c ± 0.2081 15.0c ± 0.5000 3.125 Nil
Salmonella typhi 10.0a ± 0.4509 11.0a ± 0.2516 11.0a ± 0.1527 12.0a ± 0.2645 6.250 Nil
Proteus vulgaris 10.0a ± 0.4509 12.0b ± 0.2886 14.0d ± 0.4000 16.0d ± 0.3464 3.125 Nil
Klebsiella pneumoniae 11.0a ± 0.2516 11.0a ± 0.3055 12.0b ± 0.3214 13.0b ± 0.2516 6.250 Nil
Candida albicans 10.0a ± 0.4509 18.0d ± 0.4000 20.0f ± 0.4041 24.0f ± 0.2886 0.195 Nil
Candida tropicalis 10.0a ± 0.1527 12.0b ± 0.3214 14.0d ± 0.2886 15.0c ± 0.2516 6.250 Nil
LSD 6.06666 0.83333 0.90000 0.90000
a

Values are presented as mean ± SD (n = 3). a–eData within the groups were analyzed using one-way analysis of variance (ANOVA) followed by Duncan's multiple range test (DMRT). LSD, least significant difference. Nil, no ZOI measured. AMC, amoxicillin/clavulanic acid (standard antibacterial agent). NS, nystatin (standard antifungal agent).